European Innovation Council

AMT Medical B.V., founded in 2015 and based in Ede, the Netherlands, specializes in developing innovative devices for heart bypass surgery. The company has created the AMT Heart Bypass System, which utilizes the ELANA bypass technique, originally developed by neurosurgeon Prof. Dr. C.A.F. Tulleken and his team. This minimal invasive approach aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, ultimately improving patient outcomes and recovery times. The AMT Heart Bypass System has completed its development and production processes, as well as all pre-clinical trials. A clinical multi-center trial is set to begin in late 2019 or early 2020, marking a significant step in bringing this advanced technology to the medical community.

QDI Systems B.V. is a startup based in Groningen, the Netherlands, specializing in the development of advanced imaging devices for medical applications using quantum dot technology. The company focuses on creating X-ray sensors that deliver high-contrast and high-resolution mammograms, allowing for improved diagnostic capabilities while minimizing radiation exposure for patients. QDI Systems emphasizes user-friendliness by providing accessible quantum dot materials along with comprehensive instructions for constructing high-performance imaging devices. This approach enables healthcare professionals to obtain precise medical images, enhancing the overall efficacy of diagnostic procedures.

QDI Systems B.V. is a startup based in Groningen, the Netherlands, specializing in the development of advanced imaging devices for medical applications using quantum dot technology. The company focuses on creating X-ray sensors that deliver high-contrast and high-resolution mammograms, allowing for improved diagnostic capabilities while minimizing radiation exposure for patients. QDI Systems emphasizes user-friendliness by providing accessible quantum dot materials along with comprehensive instructions for constructing high-performance imaging devices. This approach enables healthcare professionals to obtain precise medical images, enhancing the overall efficacy of diagnostic procedures.

Photon IP is a deeptech startup located in Eindhoven, the Netherlands, focused on developing advanced technologies for photonics applications. The company specializes in application-specific semiconductors that cater to various sectors, including wearable electronics and data centers. By providing innovative solutions, Photon IP supports clients in industries such as automotive and telecommunications, aiming to enhance the functionality and efficiency of their products.

GBM Works B.V., founded in 2016 and headquartered in The Hague, Netherlands, specializes in the installation of offshore wind turbine foundations. The company has developed an innovative method known as the GBM Vibro-drill, which aims to minimize ocean noise during the installation process. This technology not only enhances the efficiency of installing turbine foundations but also addresses environmental concerns by reducing disruption to marine ecosystems and nearby communities. Through its advancements, GBM Works contributes to the growth of the renewable energy sector, facilitating the expansion of offshore operations in a sustainable manner.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Qblox is a Dutch scaleup focused on quantum technology, specializing in the development of control hardware for quantum computers. The company offers patented, modular control systems that integrate hardware and software solutions designed to enhance the management of qubits. By creating a distributed processor architecture, Qblox simplifies experimental setups while improving gate fidelities through advanced electronics that reduce noise and drift. This innovation enables scientists to minimize crosstalk, implement low-latency control flows, and optimize measurement efficiency, addressing significant scientific and engineering challenges in the evolution of quantum computing. Qblox aims to support the transition from prototype quantum computers to powerful computational systems, thereby contributing to the broader advancement of quantum technology.

Microsure is a medical device company based in Eindhoven, The Netherlands, founded in 2014. It specializes in developing innovative solutions for microsurgery, a field that operates at the limits of physical capabilities. The company's flagship product is a motion stabilizer system designed specifically for microsurgeons, which enhances surgical precision by filtering out tremors and providing exceptional control during procedures. This technology allows for hybrid microsurgical procedures that enable surgeons to utilize their own instruments, thereby reducing costs for hospitals. The Microsure motion stabilizer has demonstrated its effectiveness in clinical trials, including successful operations for lymphedema. By improving the quality of microsurgical procedures, the company aims to expand treatment options for patients and facilitate the development of new, highly accurate surgical techniques.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Plasmacure is a Netherlands-based company that specializes in developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. Their patented solution effectively kills bacteria, stimulates cell proliferation, and enhances microcirculation, which helps reduce the risk of amputation. By addressing these critical aspects of wound healing, Plasmacure's technology aims to improve the quality of life for patients suffering from chronic wounds.

Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in developing advanced thermotherapy systems for treating head and neck cancers. The company's proprietary technology incorporates localized heating through an integrated microwave system, complemented by interactive software, which allows healthcare professionals to enhance traditional cancer treatments such as radiotherapy and chemotherapy. This innovative approach aims to improve patient outcomes and quality of life by mitigating the toxic effects commonly associated with standard therapies. Sensius has successfully treated seventy patients with its device, achieving a complete response rate of 81.8% at 12 weeks post-treatment. Currently, the company is working towards obtaining CE marking for its device, with significant interest from potential buyers, as it also plans to expand its application to other cancer types in the future.

Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in developing advanced thermotherapy systems for treating head and neck cancers. The company's proprietary technology incorporates localized heating through an integrated microwave system, complemented by interactive software, which allows healthcare professionals to enhance traditional cancer treatments such as radiotherapy and chemotherapy. This innovative approach aims to improve patient outcomes and quality of life by mitigating the toxic effects commonly associated with standard therapies. Sensius has successfully treated seventy patients with its device, achieving a complete response rate of 81.8% at 12 weeks post-treatment. Currently, the company is working towards obtaining CE marking for its device, with significant interest from potential buyers, as it also plans to expand its application to other cancer types in the future.

N2 Applied is a Norwegian technology company focused on revolutionizing fertilizer production for farmers. Operating from its headquarters in Oslo/Asker and with a test center in Svene, Norway, along with branches in the Netherlands and the UK, N2 Applied has developed an innovative technology that allows for the local production of fertilizer using liquid organic substrates like slurry or digestate, combined with air and electricity. This process enhances nitrogen content while preventing ammonia loss and reducing emissions, thus promoting a more sustainable farming approach. By utilizing plasma reactors, the company enables farmers to recycle livestock manure into environmentally friendly fertilizer, lowering production costs and increasing crop yields. N2 Applied's scalable solution aims to streamline the fertilizer supply chain, minimizing reliance on fossil fuel-based chemical fertilizers and contributing to on-farm reductions in methane and ammonia emissions.

Dimenco B.V. is a Netherlands-based company that specializes in 3D autostereoscopic technology, offering a range of products and services for both professional and consumer markets. Founded in 2010 and operating as a subsidiary of Top Wise International Enterprise Limited, Dimenco develops 3D displays that allow viewers to see different images without the use of special glasses. Their offerings include autostereoscopic displays, software, content conversion, and consultancy services. The company also provides tools such as the DirectX Visualizer and OpenGL Visualizer, which enable users to experience 3D applications on its displays, and the Dimenco 3D Player for playing 3D video clips. By utilizing a lenticular overlay on LCDs, Dimenco's technology enhances visual experiences, bridging the gap between excitement and reality for users.

AugmedIT B.V. is a medical software company based in Amsterdam, the Netherlands, founded in 2018. The company focuses on developing augmented and mixed reality tools that enhance surgical procedures by enabling surgeons to create holograms of patients. AugmedIT specializes in applications related to neurosurgery, medical education, and holographic visualization, as well as neuronavigation. Through its innovative technology, the company aims to improve surgical precision and training in the medical field.

Born from the MRCLEAN trial, NICO.LAB was founded in 2015 as a spin-off from the Amsterdam University Medical Center. Our research background continues to drive our way of thinking. The team consists of researchers, developers and experienced medical specialists to ensure we align with our clients needs. We believe connecting human & artificial intelligence will revolutionize emergency care. Our cloud-based solution, StrokeViewer, automatically analyses brain CT scans and gives results within minutes. StrokeViewer empowers physicians in the emergency setting to provide patients with the right treatment in time.

Dimenco B.V. is a Netherlands-based company that specializes in 3D autostereoscopic technology, offering a range of products and services for both professional and consumer markets. Founded in 2010 and operating as a subsidiary of Top Wise International Enterprise Limited, Dimenco develops 3D displays that allow viewers to see different images without the use of special glasses. Their offerings include autostereoscopic displays, software, content conversion, and consultancy services. The company also provides tools such as the DirectX Visualizer and OpenGL Visualizer, which enable users to experience 3D applications on its displays, and the Dimenco 3D Player for playing 3D video clips. By utilizing a lenticular overlay on LCDs, Dimenco's technology enhances visual experiences, bridging the gap between excitement and reality for users.

AMT Medical B.V., founded in 2015 and based in Ede, the Netherlands, specializes in developing innovative devices for heart bypass surgery. The company has created the AMT Heart Bypass System, which utilizes the ELANA bypass technique, originally developed by neurosurgeon Prof. Dr. C.A.F. Tulleken and his team. This minimal invasive approach aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, ultimately improving patient outcomes and recovery times. The AMT Heart Bypass System has completed its development and production processes, as well as all pre-clinical trials. A clinical multi-center trial is set to begin in late 2019 or early 2020, marking a significant step in bringing this advanced technology to the medical community.

Dawn Aerospace is a company that designs and manufactures reusable spacecraft and non-toxic propulsion systems for satellites. Founded in 2016 and headquartered in Delft, Netherlands, with facilities in Auckland, New Zealand, Dawn Aerospace focuses on developing same-day reusable launch vehicles that integrate with conventional aircraft, allowing for frequent and routine launches similar to commercial aviation. Their product line includes the MK-1, MK-2, MK-3, and MK-4 vehicles. In addition, the company offers high-performance propulsion systems that replace toxic fuels, like hydrazine, with safer alternatives, enhancing capabilities for satellites of various sizes, including CubeSats. By combining these technologies, Dawn Aerospace aims to create a scalable and environmentally friendly architecture for satellite delivery, positioning, and return.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Quanturi Oy is a Finnish company founded in 2016 and headquartered in Espoo, specializing in continuous monitoring solutions for fermentable products. The company develops and markets connected objects and systems for data analysis, focusing on agricultural, forestry, and waste management sectors. Its product offerings include wireless monitoring systems for compost temperature, grain management, hay monitoring, and other industrial temperature applications. Quanturi Oy also sells its products online and has expanded its presence to several countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium.

SolarDew, based in Rhenen, the Netherlands, specializes in innovative membrane distillation technology that efficiently generates pure drinking water from contaminated or saline sources. The company develops modular desalination and purification systems powered solely by solar energy, eliminating the need for external power sources. This approach not only addresses water scarcity but also empowers local entrepreneurs to establish and manage water purification businesses within their communities. By providing a sustainable solution for water quality improvement, SolarDew contributes to enhanced access to safe drinking water.

GBM Works B.V., founded in 2016 and headquartered in The Hague, Netherlands, specializes in the installation of offshore wind turbine foundations. The company has developed an innovative method known as the GBM Vibro-drill, which aims to minimize ocean noise during the installation process. This technology not only enhances the efficiency of installing turbine foundations but also addresses environmental concerns by reducing disruption to marine ecosystems and nearby communities. Through its advancements, GBM Works contributes to the growth of the renewable energy sector, facilitating the expansion of offshore operations in a sustainable manner.

SolarDew, based in Rhenen, the Netherlands, specializes in innovative membrane distillation technology that efficiently generates pure drinking water from contaminated or saline sources. The company develops modular desalination and purification systems powered solely by solar energy, eliminating the need for external power sources. This approach not only addresses water scarcity but also empowers local entrepreneurs to establish and manage water purification businesses within their communities. By providing a sustainable solution for water quality improvement, SolarDew contributes to enhanced access to safe drinking water.

Quanturi Oy is a Finnish company founded in 2016 and headquartered in Espoo, specializing in continuous monitoring solutions for fermentable products. The company develops and markets connected objects and systems for data analysis, focusing on agricultural, forestry, and waste management sectors. Its product offerings include wireless monitoring systems for compost temperature, grain management, hay monitoring, and other industrial temperature applications. Quanturi Oy also sells its products online and has expanded its presence to several countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium.

ATRO Medical B.V., based in Nijmegen, the Netherlands, focuses on developing innovative solutions for knee joint health through its anatomically shaped meniscus implant, the Trammpolin. This implant is designed to restore the protective function of the meniscus by acting as a joint spacer, thus alleviating pain and improving life quality for patients suffering from osteoarthritis. The company emerged as a spin-out from DSM and Radboudumc, leveraging insights gained from a collaborative initiative that began in 2010, involving various universities and private enterprises with support from the Dutch government. The Trammpolin prosthesis is a synthetic, non-resorbable substitute that mimics the natural meniscus, functioning effectively as a shock absorber by ensuring adequate load distribution within the knee joint.

Hy2Care BV is a start-up based at the University of Twente in the Netherlands, focused on developing a groundbreaking treatment for osteoarthritis, a condition affecting over 100 million patients in the Western world. The company's primary product is an injectable hydrogel, designed to repair cartilage defects, particularly in the knee. This bioresorbable hydrogel consists of a two-component system made from natural polymer conjugates that undergo a mild enzymatic reaction to create a functional repair solution for cartilage damage. Hy2Care aims to significantly improve the quality of life for individuals suffering from osteoarthritis by providing an effective and innovative treatment option.

Hy2Care BV is a start-up based at the University of Twente in the Netherlands, focused on developing a groundbreaking treatment for osteoarthritis, a condition affecting over 100 million patients in the Western world. The company's primary product is an injectable hydrogel, designed to repair cartilage defects, particularly in the knee. This bioresorbable hydrogel consists of a two-component system made from natural polymer conjugates that undergo a mild enzymatic reaction to create a functional repair solution for cartilage damage. Hy2Care aims to significantly improve the quality of life for individuals suffering from osteoarthritis by providing an effective and innovative treatment option.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Allero Therapeutics B.V. is a biopharmaceutical company based in Rotterdam, the Netherlands, founded in 2016. The company specializes in developing programmed immunotherapies aimed at treating immune-mediated disorders. Utilizing its Specific Oromucosal Immunotherapy (SOMIT) platform, Allero Therapeutics focuses on restoring immune tolerance through the targeted delivery of antigen-specific therapies. This innovative approach is based on research conducted by the founders and their collaborators, enabling the induction of long-lasting antigen-specific tolerance. The technology is designed to address a variety of clinical indications with significant unmet medical needs, particularly in the fields of allergic and autoimmune diseases.

N2 Applied is a Norwegian technology company focused on revolutionizing fertilizer production for farmers. Operating from its headquarters in Oslo/Asker and with a test center in Svene, Norway, along with branches in the Netherlands and the UK, N2 Applied has developed an innovative technology that allows for the local production of fertilizer using liquid organic substrates like slurry or digestate, combined with air and electricity. This process enhances nitrogen content while preventing ammonia loss and reducing emissions, thus promoting a more sustainable farming approach. By utilizing plasma reactors, the company enables farmers to recycle livestock manure into environmentally friendly fertilizer, lowering production costs and increasing crop yields. N2 Applied's scalable solution aims to streamline the fertilizer supply chain, minimizing reliance on fossil fuel-based chemical fertilizers and contributing to on-farm reductions in methane and ammonia emissions.

Do you want to use your green roof to power your house? Would you like to see each wetland and rice paddy field in the world turned into a power plant without harvesting the plants? Plant-e is a company that develops and produces products in which living plants generate electricity. The company was founded on September 14, 2009 as a spin-off from the sub-department of Environmental Technology of Wageningen University by Marjolein Helder and David Strik. Since her PhD-graduation in November 2012 Marjolein is working full-time as CEO of Plant-e. David works as an assistant professor at Wageningen University and still is an important link between scientific research and the research and development at Plant-e.

Microsure is a medical device company based in Eindhoven, The Netherlands, founded in 2014. It specializes in developing innovative solutions for microsurgery, a field that operates at the limits of physical capabilities. The company's flagship product is a motion stabilizer system designed specifically for microsurgeons, which enhances surgical precision by filtering out tremors and providing exceptional control during procedures. This technology allows for hybrid microsurgical procedures that enable surgeons to utilize their own instruments, thereby reducing costs for hospitals. The Microsure motion stabilizer has demonstrated its effectiveness in clinical trials, including successful operations for lymphedema. By improving the quality of microsurgical procedures, the company aims to expand treatment options for patients and facilitate the development of new, highly accurate surgical techniques.

Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in developing advanced thermotherapy systems for treating head and neck cancers. The company's proprietary technology incorporates localized heating through an integrated microwave system, complemented by interactive software, which allows healthcare professionals to enhance traditional cancer treatments such as radiotherapy and chemotherapy. This innovative approach aims to improve patient outcomes and quality of life by mitigating the toxic effects commonly associated with standard therapies. Sensius has successfully treated seventy patients with its device, achieving a complete response rate of 81.8% at 12 weeks post-treatment. Currently, the company is working towards obtaining CE marking for its device, with significant interest from potential buyers, as it also plans to expand its application to other cancer types in the future.

Qblox is a Dutch scaleup focused on quantum technology, specializing in the development of control hardware for quantum computers. The company offers patented, modular control systems that integrate hardware and software solutions designed to enhance the management of qubits. By creating a distributed processor architecture, Qblox simplifies experimental setups while improving gate fidelities through advanced electronics that reduce noise and drift. This innovation enables scientists to minimize crosstalk, implement low-latency control flows, and optimize measurement efficiency, addressing significant scientific and engineering challenges in the evolution of quantum computing. Qblox aims to support the transition from prototype quantum computers to powerful computational systems, thereby contributing to the broader advancement of quantum technology.

Qblox is a Dutch scaleup focused on quantum technology, specializing in the development of control hardware for quantum computers. The company offers patented, modular control systems that integrate hardware and software solutions designed to enhance the management of qubits. By creating a distributed processor architecture, Qblox simplifies experimental setups while improving gate fidelities through advanced electronics that reduce noise and drift. This innovation enables scientists to minimize crosstalk, implement low-latency control flows, and optimize measurement efficiency, addressing significant scientific and engineering challenges in the evolution of quantum computing. Qblox aims to support the transition from prototype quantum computers to powerful computational systems, thereby contributing to the broader advancement of quantum technology.

Avy is an Amsterdam-based company specializing in the development and operation of vertical take-off and landing (VTOL) drones aimed at enhancing emergency services and healthcare logistics. The company provides an integrated range of drone solutions that allow emergency responders, such as fire departments, police, and ambulance services, to access remote locations within minutes. Avy's drone networks are designed for long-range operations and are particularly focused on medical deliveries and wildlife conservation efforts. By utilizing a zero-emission portfolio, Avy enables clients to achieve full autonomy in their operations while significantly reducing costs and improving response times.

Avy is an Amsterdam-based company specializing in the development and operation of vertical take-off and landing (VTOL) drones aimed at enhancing emergency services and healthcare logistics. The company provides an integrated range of drone solutions that allow emergency responders, such as fire departments, police, and ambulance services, to access remote locations within minutes. Avy's drone networks are designed for long-range operations and are particularly focused on medical deliveries and wildlife conservation efforts. By utilizing a zero-emission portfolio, Avy enables clients to achieve full autonomy in their operations while significantly reducing costs and improving response times.

Hiber, founded in 2016 and based in Amsterdam, Netherlands, specializes in providing global and affordable IoT connectivity through its innovative Hiberband platform. The company has developed a nano-satellite system designed to offer low-cost data connectivity for sensors worldwide. This platform facilitates easy, low-power access to a network, enabling users to gather and transmit small data packages from monitoring devices located anywhere on the planet. By simplifying the installation of its modem in various devices, Hiber allows for efficient data collection and actionable insights, positioning itself as a leader in next-generation IoT core infrastructure.

Plasmacure is a Netherlands-based company that specializes in developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. Their patented solution effectively kills bacteria, stimulates cell proliferation, and enhances microcirculation, which helps reduce the risk of amputation. By addressing these critical aspects of wound healing, Plasmacure's technology aims to improve the quality of life for patients suffering from chronic wounds.

Plasmacure is a Netherlands-based company that specializes in developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. Their patented solution effectively kills bacteria, stimulates cell proliferation, and enhances microcirculation, which helps reduce the risk of amputation. By addressing these critical aspects of wound healing, Plasmacure's technology aims to improve the quality of life for patients suffering from chronic wounds.

Hiber, founded in 2016 and based in Amsterdam, Netherlands, specializes in providing global and affordable IoT connectivity through its innovative Hiberband platform. The company has developed a nano-satellite system designed to offer low-cost data connectivity for sensors worldwide. This platform facilitates easy, low-power access to a network, enabling users to gather and transmit small data packages from monitoring devices located anywhere on the planet. By simplifying the installation of its modem in various devices, Hiber allows for efficient data collection and actionable insights, positioning itself as a leader in next-generation IoT core infrastructure.